Corvus Pharmaceuticals
CRVS
CRVS
87 hedge funds and large institutions have $115M invested in Corvus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.5% less ownership
Funds ownership: 58.72% → 53.23% (-5.5%)
43% less capital invested
Capital invested by funds: $202M → $115M (-$86.5M)
Holders
87
Holding in Top 10
2
Calls
$4.72M
Puts
$1.93M
Top Buyers
| 1 | +$4.71M | |
| 2 | +$1.27M | |
| 3 | +$884K | |
| 4 |
Morgan Stanley
New York
|
+$878K |
| 5 |
Two Sigma Advisers
New York
|
+$695K |
Top Sellers
| 1 | -$8.27M | |
| 2 | -$5.35M | |
| 3 | -$937K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$771K |
| 5 |
Goldman Sachs
New York
|
-$688K |
